0000899243-20-005917.txt : 20200226 0000899243-20-005917.hdr.sgml : 20200226 20200226171257 ACCESSION NUMBER: 0000899243-20-005917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200127 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZEIN YOUSSEF EL CENTRAL INDEX KEY: 0001193366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657042 MAIL ADDRESS: STREET 1: HYBRIDON INC STREET 2: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Umari Abude CENTRAL INDEX KEY: 0001783582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657043 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Partners Foundation, L.P. CENTRAL INDEX KEY: 0001783583 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657044 BUSINESS ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals 6, L.P. CENTRAL INDEX KEY: 0001783584 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657045 BUSINESS ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals V LP CENTRAL INDEX KEY: 0001687312 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657046 BUSINESS ADDRESS: STREET 1: PILLAR PHARMACEUTICALS V LP STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: E9 ZIP: 02210 BUSINESS PHONE: 617-570-1496 MAIL ADDRESS: STREET 1: PILLAR PHARMACEUTICALS V LP STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: E9 ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals IV, L.P. CENTRAL INDEX KEY: 0001588130 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657047 BUSINESS ADDRESS: STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals III, L.P. CENTRAL INDEX KEY: 0001576891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657048 BUSINESS ADDRESS: STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CENTER, BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P. CENTRAL INDEX KEY: 0001562069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657049 BUSINESS ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 9611363362 MAIL ADDRESS: STREET 1: STARCO CENTER BLOC B, THIRD FLOOR STREET 2: OMAR DAOUK STREET CITY: BEIRUT 2020-3313 STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Pharmaceuticals I LP CENTRAL INDEX KEY: 0001534425 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657050 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 20657051 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-27 1 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001534425 Pillar Pharmaceuticals I LP PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001562069 Pillar Pharmaceuticals II, L.P. PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001576891 Pillar Pharmaceuticals III, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001588130 Pillar Pharmaceuticals IV, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001687312 Pillar Pharmaceuticals V LP PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783584 Pillar Pharmaceuticals 6, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783583 Pillar Partners Foundation, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783582 Umari Abude PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001193366 ZEIN YOUSSEF EL PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 Common Stock 2020-01-27 4 S 0 15000 1.77 D 3284224 I See Footnote Common Stock 2020-01-28 4 S 0 12532 1.762 D 3271692 I See Footnote Common Stock 2020-01-29 4 S 0 17250 1.7645 D 3254442 I See Footnote Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 21,100 shares of common stock of the Issuer. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 20,820 shares of common stock of the Issuer. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.7707. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following the transactions on 1/28/20 and 1/29/20, Pillar III owns directly 29,998 shares of common stock of the Issuer. Shares sold by Pillar Pharmaceuticals V, L.P. ("Pillar V"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar V and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar V. Following this transaction, Pillar V owns directly 25,000 shares of common stock of the Issuer. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2020-02-26